Vidasym, Inc.

Libertyville, IL 60048

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $2.65MM
First Award Date 09/20/11
Most Recent Award Date 04/01/16

Key Personnel

Last Name Name Awards Contact
Li Yan Chun Li 2
Wu-Wong Jinshyun Ruth Wu-Wong 6

6 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 04/01/16 - 03/31/17

? DESCRIPTION (provided by applicant): Osteoporosis is a major public health threat. The American Association of Orthopaedic Surgeons estimates that the cost of treating patients with a low-energy fracture in 2004 was US$24.2 billion, and projected costs for care of osteoporosis and low-energy fractures over the next two decades are $474 bil...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-12-089
Budget: 09/15/13 - 08/31/14

DESCRIPTION (provided by applicant): Inflammatory bowel diseases (IBD) involve chronic inflammation of all or part of the digestive tract. Symptoms may include abdominal pain, severe diarrhea and malnutrition. IBD primarily includes ulcerative colitis (UC) and Crohn's disease (CD). In the West, the prevalence has increased in the past 50 years t...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/01/13 - 04/30/14

DESCRIPTION (provided by applicant): Osteoporosis is a major public health threat. National Osteoporosis Foundation estimated that the US national direct expenditures for osteoporotic hip fractures were at $17 billion in 2005 and it would increase to $25 billion in 2025. Current treatments for osteoporosis include several anti-resorptive (or an...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-11-097
Budget: 09/01/12 - 08/31/13

DESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Diabetes is by far the leading cause of CKD (diabetic nephropathy), accounting for 44% of new cases of dialysis (in 2005). Current treatments including ACE inhibitors for CKD patients mainly focus on managing symptoms and disease complica...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 09/01/12 - 04/30/13

DESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Despite the various treatments available to CKD patients, the five-year survival rate is ~33%. Inadequately controlled serum phosphate levels in CKD can lead to various pathologies of clinical importance such as further deterioration of k...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 09/20/11 - 03/30/13

DESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Anemia, cardiovascular diseases, secondary hyperparathyroidism, renal osteodystrophy and other complications are common in CKD. Current treatments including ACE inhibitors for CKD patients mainly focus on managing symptoms and disease com...